Remix Therapeutics is advancing a new class of therapeutics by modulating RNA processing with small molecules. The company focuses on drug discovery programs that target previously undrugged oncogenic transcription factors to develop innovative therapies for cancer and other diseases.

Remix Therapeutics is advancing a new class of therapeutics by modulating RNA processing with small molecules. The company focuses on drug discovery programs that target previously undrugged oncogenic transcription factors to develop innovative therapies for cancer and other diseases.